REDUCTION OF LDL CHOLESTEROL BY PRAVASTATIN DOES NOT INFLUENCE PLATELET ACTIVATION IN PATIENTS WITH MILD HYPERCHOLESTEROLEMIA AT RISK OF CORONARY HEART-DISEASE

被引：17

作者：

BARROW, SE ^{[1
]}

STRATTON, PD ^{[1
]}

BENJAMIN, N ^{[1
]}

BRASSFIELD, T ^{[1
]}

RITTER, JM ^{[1
]}

机构：

[1] BRISTOL MYERS SQUIBB PHARMACEUT,CLIN RES DEPT,HOUNSLOW TW3 3JA,MIDDX,ENGLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1991年 / 32卷 / 01期

关键词：

THROMBOXANE A2; PLATELET ACTIVATION; PRAVASTATIN; LDL; HYPERCHOLESTEROLEMIA;

D O I：

10.1111/j.1365-2125.1991.tb05625.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The effect of pravastatin on low density lipoprotein (LDL) cholesterol and platelet activation was studied in 16 patients with mild hypercholesterolaemia who had two or more additional cardiovascular risk factors. Patients were treated with either pravastatin (20-40 mg day-1) or placebo for 1 year. Plasma LDL and urinary excretion of 2,3-dinor-thromboxane B2 (an index of platelet activation in vivo) were determined at 0, 3, 6 and 12 months. There was a significant reduction in LDL at 6 and 12 months (2P < 0.05) but this was not associated with any significant change in thromboxane metabolite excretion.

引用

页码：127 / 129

页数：3

共 50 条

[21] CHOLESTEROL METABOLISM IN PATIENTS WITH CORONARY HEART-DISEASE
MIETTINEN, TA
ANNALS OF CLINICAL RESEARCH, 1971, 3 (06): : 313 - +
[22] OVERPRODUCTION OF LDL IN HYPERTRIGLYCERIDEMIC PATIENTS WITH CORONARY HEART-DISEASE
VEGA, GL
BELTZ, W
GRUNDY, SM
ARTERIOSCLEROSIS, 1983, 3 (05): : A486 - A486
[23] Coronary heart disease in patients with low LDL-cholesterol - Benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors
Sacks, FM
Tonkin, AM
Craven, T
Pfeffer, MA
Shepherd, J
Keech, A
Furberg, CD
Braunwald, E
CIRCULATION, 2002, 105 (12) : 1424 - 1428
[24] RISK FACTOR REDUCTION IN CORONARY HEART-DISEASE
KULLER, L
MODERN CONCEPTS OF CARDIOVASCULAR DISEASE, 1984, 53 (02) : 7 - 11
[25] INFLUENCE OF TREATMENT OF MILD HYPERTENSION ON CORONARY HEART-DISEASE
STAMLER, R
ACTA MEDICA SCANDINAVICA, 1985, : 89 - 99
[26] CHOLESTEROL AND RISK OF CORONARY HEART-DISEASE AND MORTALITY IN MEN
KANNEL, WB
CLINICAL CHEMISTRY, 1988, 34 (8B) : B53 - B59
[27] HDL CHOLESTEROL AS RISK FACTOR IN CORONARY HEART-DISEASE
ASSMANN, G
SCHRIEWER, H
SCHULTE, H
OBERWITTLER, W
INTERNIST, 1980, 21 (04): : 202 - 212
[28] DOES LOWERING SERUM-CHOLESTEROL LEVELS LOWER CORONARY HEART-DISEASE RISK
ROSSOUW, JE
RIFKIND, BM
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1990, 19 (02) : 279 - 297
[29] THE CONTROVERSIAL ROLE OF DIETARY-CHOLESTEROL AND HYPERCHOLESTEROLEMIA IN CORONARY HEART-DISEASE AND ATHEROGENESIS
STEHBENS, WE
PATHOLOGY, 1989, 21 (03) : 213 - 221
[30] Influence of LDL-apheresis on LDL-subspecies in patients with coronary heart disease (CHD) and severe LDL-hypercholesterolemia
Geiss, HC
Schamberger, B
Ritter, MM
Parhofer, KG
Schwandt, P
ATHEROSCLEROSIS, 1999, 144 : 65 - 65

← 1 2 3 4 5 →